The Emergence of Cancer in Belgium

Author: Philippe Paeps

Ever wondered how cancer went from a largely hidden condition to one of the most closely monitored diseases in public health? This article takes you on a journey through Belgium’s history, showing how medical progress, unequal diagnostic capacity, and changing ways of life shaped who was counted and who was missed.  

Discover how cancer became “visible”, how its recorded burden changed over time, and what historical data reveal about the social and spatial inequalities that still matter today. 

What is Cancer?

What is Dementia

Dementia is a syndrome of cognitive decline, affecting memory, reasoning, language, and daily activities. It results from neurodegenerative diseases like Alzheimer’s.

Where Does Dementia occur

Dementia primarily affects older adults, making it prevalent in high-income countries with ageing populations. The global burden is increasing.

What is Dementia

Dementia is a syndrome of cognitive decline, affecting memory, reasoning, language, and daily activities. It results from neurodegenerative diseases like Alzheimer’s.

What is Dementia

Dementia is a syndrome of cognitive decline, affecting memory, reasoning, language, and daily activities. It results from neurodegenerative diseases like Alzheimer’s.

A historical case of cancer

In 1845, the medical journal Annales de la Société de Médecine d’Anvers reported the case of a 38-year-old Belgian lace-maker, known as Madame L., who sought medical help for a small, hard lump in her breast. Described as frail and having suffered convulsions during earlier pregnancies, she soon encountered the limits of contemporary medicine. 

Her first physician, Dr. Heylen from Herentals, ruled out inflammation and prescribed treatments commonly used at the time, including iodine, hemlock extract, and poultices. When these failed, surgery was proposed, but Madame L. feared the “cutting instrument.” A second doctor repeated similar remedies, adding leeches, yet the tumour continued to grow. 

Within months, the skin became inflamed and ulcerated, and the mass expanded dramatically, described as the size of “three fists” and exuding a whitish, brain-like substance. With no other options left, a breast amputation was finally performed on 30 July 1845. 

This case illustrates how, before modern diagnostic tools and effective treatments, cancer was often recognised late and allowed to progress until surgery became the only possible intervention (see Figure 1). 

A full breast amputation

Nicolas Henri Jacob, Removal of the Breast, from J.B.M. Bourgery and Claude Bernard, Traité Complet de l'Anatomie de l'Homme (Paris: 1832-1854), Vol. 7 (1866-1871), Plate 27, coloured lithograph. Wellcome Collection. Digital image courtesy of Wellcome Collection (CC BY 4.0).

A Brief History of Cancer

Cancer is often perceived as a modern disease, yet people have lived with it for millennia. Ancient Egyptian texts dating back to around 2500 BC already described tumours treated with cauterization. In the fourth and fifth centuries BC, Hippocrates coined the term karkinos, comparing tumours to crabs because of their claw-like appearance. For centuries, physicians explained cancer through the theory of the four bodily humours, attributing it to an excess of black bile. 

For most of history, cancer was closely associated with pain, suffering, and death. Effective treatments were scarce and cures rare. Tumours were often described as living, devouring entities, hostile and unstoppable. Patients frequently delayed seeking medical help until pain became unbearable. Surgery was sometimes attempted, but before the late nineteenth century it was performed without anaesthesia or antisepsis and was therefore deeply feared. Many patients turned to folk remedies instead, usually without success. 

Like other feared diseases of the past, cancer was likely surrounded by social stigma, which may have discouraged care seeking and also affected how deaths were recorded, although this still must be demonstrated for Belgium. Only in the mid-nineteenth century did scientific understanding begin to shift. In the 1860s, surgeon-pathologist Rudolf Virchow showed that cancer originates in cells, marking a decisive break with humoral explanations and laying the foundation for modern cancer diagnosis. 

In the following decades, new innovations related to the microscope and biopsy techniques slowly improved diagnosis and treatment options. Belgium was also an early adopter of X-ray technology and during the interbellum, physicians like Joseph Maisin pioneered in cancer radiation treatment. He believed that cancer was not the consequence of personal misfortune, but part of a broader social problem that can be remedied through prevention and treatment. This hopeful climate attracted charlatans in pseudo-medical institutions eager to profit from the rising demand for cures. Advertisements for cancer treatments routinely appeared in reputable Belgian newspapers, in which possible treatments were published alongside the names of cured patients and the cancers they had suffered (see figure 2).

“Cure Cancer, Glands, etc. Without Operation…”

Nieuws van de dag
Nieuws van de Dag, 14-02-1897, 4 (KBR Belgica Press online).

How was cancer counted?

In 1851, cancer accounted for roughly one percent of all recorded deaths nationwide, far below major killers such as tuberculosis. Classification was rudimentary. Cancers were grouped into only a few anatomical categories, mainly the mouth, stomach, uterus, and breast, the most prevalent ones. Tumeurs formed a separate and highly heterogeneous group, including conditions that would not be considered malignant today.

In the early nineteenth century, cancer was recognized through what could be seen, felt, or even smelled. Diagnosis relied on external appearance rather than laboratory confirmation (as is the current practice). Ideally, causes of death were diagnosed and recorded by doctors. However, especially in rural areas, the deceased’s family or municipal clerks often reported on causes of death without medical training, using imprecise and inconsistent terminology. Confusion between cancer, other chronic conditions (e.g. ulcers), and vague categories such as old age was common.

Although medical knowledge on cancer entered a transitional phase from the 1860s onward, cancer remained poorly captured in official statistics until well into the twentieth century. In Belgium, causes of death were published annually in the Mouvement de la Population et de l’Etat civil from 1851, but national data on general cancer mortality are only available from 1903 onward (see table for first mention). Before, public health authorities perceived infectious diseases as the more obvious public health threat that should be monitored and controlled. Between 1870 and 1902, no national cancer statistics were preserved, although some municipalities kept detailed local registers.

Cancer in the Mouvement: Grouped cancer deaths by province and sex

Source: SA, Mouvement de la Population et de L’Etat civil (1903, 97).

Although municipalities recorded cancer deaths by type in their local registers, the national statistics reported on cancer as a single category. In other words, information that existed at the local level was deliberately merged at the national level. This choice was not accidental, but a reflection of the time: medical knowledge was limited, and authorities were cautious when confronted with diverging medical practices in the more than 2000 Belgian municipalities. Only from the mid-1950s onward did Belgium, like many other countries, begin to register cancer deaths by type nationally. Detailed data on incidence would only become available decades later.

Registration practices matter. Our analyses show that in districts where recorded cancer mortality was high, deaths attributed to old age or ill-defined causes tended to be low, and vice versa (see maps), suggesting substantial under-registration of cancer in areas with limited diagnostic capacity. Historical cancer trends therefore mirror both real changes in risk, linked to ageing and lifestyle, and artificial increases driven by improved diagnosis and registration. We estimate that around one third of cancer deaths may have gone unrecorded in 1910, declining gradually to roughly fifteen percent by mid-century.

Cancer versus old age (1930s)

Source : HISSTER, own calculations (INEQKILL) 

Historical cancer trends in Belgium

As infectious diseases recede, cancer becomes more prominent. This shift is a well-known feature of the epidemiological transition, but it does not affect all places or social groups in the same way. The risk of dying from cancer is caused by a combination of long-term exposures and living conditions, related to smoking, alcohol use, diet, work environments, and air quality. Many cancers are therefore partly preventable, depending on the knowledge, resources, and treatments available. 

In Belgium, recorded cancer mortality rose steadily during the early twentieth century, coinciding with rising life expectancy. Life expectancy rose from just over 40 years around 1850 to more than 65 years by 1950, allowing more people to reach ages at which cancer becomes common. 

For a long time, cancer was perceived as a “female” disease, because breast and uterus cancers were more frequently detected by physicians, while many male cancers remained underdiagnosed.  

Until the mid-1950s, women indeed showed slightly higher recorded cancer mortality than men in our sources. After that point, the pattern drastically reversed. Male cancer mortality rose sharply, peaking in the late twentieth century, before gradually declining. In recent decades, male and female rates have begun to converge. These shifting patterns were shaped by behaviour and exposure, such as men’s historically higher smoking rates and occupational risks. More recently, rising smoking uptake among women has narrowed the gap between male and female cancer mortality. 

Crude Cancer Mortality by Sex (per 100.000 persons)

Figure 3 : Belgian statistics, calculations by author

Spatial Inequalities

Clear regional differences in cancer mortality emerged early in Belgium. Between 1905 and 1948, the highest age-standardized cancer mortality rates – although still low in comparison to later on – were observed in Flanders, a pattern likely linked to the prevalence of cancers of the stomach, liver, and breast. At the same time, cancer deaths clustered in major cities such as Brussels, Antwerp, Liège, and Ghent, and in a corridor running from Antwerp towards Kortrijk. Particularly high rates were also recorded in the district of Philippeville, along the French border. 

From the 1970s onward, the geography of cancer mortality shifted. Highest rates became increasingly concentrated in Wallonia, largely driven by male lung cancer mortality. Across all periods, however, a striking paradox remains: elevated cancer mortality appears in both urban and rural districts, on either side of the language border. This suggests that spatial inequalities cannot be reduced to a single cause such as smoking, but reflect a complex interplay of exposure, lifestyle, and diagnostic practices. 

Standard Mortality Rate for Men 1910-1930-1947-1970-1990

Source: 

Standard Mortality Rate for Women 1910-1930-1947-1970-1990

Source: 

Were inequalities always there?

At first sight, today’s social inequalities in cancer mortality may seem self-evident. Disadvantaged groups die more often from cancer, while better-off groups tend to live longer. But history tells a more complicated story. 

To understand long-term patterns in cancer mortality, we need to look beyond cancer as a single disease and consider cancer by type and the determinants of cancer mortality.   

First, incorporating cancer by type is easier said than done as site-specific cancer data only become available from the early 1960s onward. Once these data appear, however, clear contrasts emerge. Stomach cancer, for example, is common in the early postwar years but falls sharply thereafter. This decline is linked to long-term improvements in living conditions: better food preservation through refrigeration, less reliance on salted and smoked foods, improved nutrition, and falling infection rates with Helicobacter pylori. Lung cancer follows the opposite trajectory. From the 1960s to the early 1990s, mortality rose steeply, especially among men, reflecting the delayed effects of widespread smoking combined with occupational and environmental exposures. 

These diverging trends are often described as part of the cancer transition: a long-term shift from cancers closely associated with infections and poor living conditions (stomach, liver, or cervical cancer) towards cancers linked to lifestyle, ageing, and non-infectious processes (e.g. lung, breast, colorectal, and prostate cancer). In most Western countries, this transition unfolded gradually between the 1930s and the 1960s. 

Interestingly, local research suggests that this transition did not occur everywhere at the same pace. In the city of Antwerp, the shift towards non-infectious, lifestyle-related cancers appears to have taken place already in the late 1930s, roughly two decades earlier than at the national level. There, recorded mortality from non-infectious cancers was initially higher among more advantaged groups. The reason was not better protection due to knowledge, but the opposite: wealthier groups adopted risky behaviours, such as smoking, earlier. By contrast, cancers linked to infections and poor living conditions showed little social differentiation, largely because no one yet knew how to prevent them. 

Secondly, direct data on historical risk behaviours such as smoking or alcohol consumption are largely absent. To fill this gap, we rely on socioeconomic indicators such as literacy, income, and occupational structure of the population. Doing so reveals another striking finding: early in the twentieth century, social gradients in cancer mortality were weak, inconsistent, or even absent. This means that who died from cancer depended less on social position than on chance or local registration practices. Without effective prevention, diagnosis, or treatment, social advantage offered little protection. 

That began to change after the Second World War. From the late 1940s onward, socioeconomic inequalities in cancer mortality became more pronounced, particularly among men. This suggest gendered access to information, prevention, and care. Between 1948 and 1970, the direction of the social gradient reversed, in line with international evidence and our own hypothesis: as knowledge improves, social resources increasingly translated into survival advantages. 

One caveat remains crucial. Our most telling results are related to registration quality. Areas with high proportions of deaths recorded as “old age” or “ill-defined” consistently show lower recorded cancer mortality. This pattern reveals substantial under-registration. In other words, part of the observed inequalities are based on who was diagnosed and counted, and who was not. These practices differed enormously between regions. 

Finally, a methodological note: our analyses are conducted at the district level. At the municipal level, cancer deaths were often too few to produce stable rates. Aggregating to districts allows meaningful comparisons while still capturing long-term spatial variation. 

Conclusions

Historical data reveal that early cancer mortality statistics were likely shaped more by diagnostic and registration practices rather than by socioeconomic differences at first. In the first half of the twentieth century, districts with limited medical infrastructure systematically underreported cancer deaths, masking inequalities. As diagnostic standards improved during the mid-twentieth century, socioeconomic inequalities in cancer mortality became more visible. However, the lack of systematic data by cancer type limits how precisely we can reconstruct these early disparities. 

Further Reading

Want to know more about our research on cancer ? You can explore our published articles below.

  • Philippe Paeps, Isabelle Devos, Sylvie Gadeyne, Sven Vrielinck and Torsten Wiedemann, “Tracing the tumors: navigating challenges in mapping cancer trends across twentieth-century Belgium”, Espace populations sociétés [Online], 2023/3-2024/1 | 2024, Online since 13 November 2024, connection on 09 December 2025. URL: http://journals.openedition.org/eps/14597 ; DOI: https://doi.org/10.4000/12tpv

Sources and Literature

  • Alanna Skuse, Constructions of Cancer in Early Modern England. Ravenous Natures. Basingstoke: Palgrave Macmillan, 2015.
  • Daniel Droixhe, Fer ou ciguë ? Récits sur le cancer du sein au 18e siècle. Brussels : Académie royale de Belgique, 2015.
  • Steven Hajdu, A note from History (series of articles between 2011 and 2016)
  • Barbara Clow, Who’s Afraid of Susan Sontag? or, the Myths and Metaphors of Cancer Reconsidered, Social History of Medicine, Vol. 14, No. 2 (2001): pp. 293-312.
  • Siddhartha Mukherjee, The Emperor of All Maladies. A Biography of Cancer. New York: Scribner, 2011.
  • Tytgat, E, en Hector De Stella. Sociale plagen : alkoolisme, tuberculose, venerische ziekten, kanker, beperking der geboorten. Gent: Het Volk, 1917(?).
  • n., Belgian scientists and doctors and radium: a brief but intense nuclear affair, 2025. https://www.bestor.be/wiki_en/index.php/Belgian_scientists_and_doctors_and_radium:_a_brief_but_intense_nuclear_affair
  • Clouston et al. 2016